• Sanara MedTech held its annual shareholder meeting on June 4, 2026.
• Shareholders backed the slate of director nominees for one-year terms.
• Appointment of Weaver and Tidwell as independent auditor for the fiscal year ending Dec. 31, 2026 was ratified.
• Advisory support was recorded for executive pay, though it does not itself implement compensation changes.
• Advisory vote favored holding future executive-pay votes every three years; the board set a three-year schedule through the next expected frequency vote in 2029.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sanara Medtech Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-027936), on June 09, 2026, and is solely responsible for the information contained therein.